naproxen has been researched along with hydroxychloroquine in 10 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (hydroxychloroquine) | Trials (hydroxychloroquine) | Recent Studies (post-2010) (hydroxychloroquine) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 5,885 | 474 | 4,041 |
| Protein | Taxonomy | naproxen (IC50) | hydroxychloroquine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 2.951 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 4.772 | |
| Toll-like receptor 9 | Homo sapiens (human) | 0.11 | |
| Toll-like receptor 7 | Homo sapiens (human) | 3.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rothenberg, RJ; Sufit, RL | 1 |
| Dickstein, K; Omdal, R; von Brandis, C | 1 |
| Baum, J | 1 |
| Baethge, B; Botstein, GR; Caldwell, J; Dietz, F; Ettlinger, R; Furst, DE; Golden, HE; Lindsley, H; McLaughlin, GE; Moreland, LW; Roberts, WN; Rooney, TW; Rothschild, B; Sack, M; Sebba, AI; Weisman, M; Welch, KE; Yocum, D | 1 |
| Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
| Fernandez Penas, P; Ruiz Beguerie, J; Sharma, R | 1 |
| Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N | 1 |
| Abdel-Daim, MM; Akhtar, MF; Alsharif, KF; Saleem, A; Zubair, S | 1 |
| Clark, S; Clees, WI; Elkin, KR; Elliott, HA; Hayden, KR; Jones, M; Mashtare, ML; Preisendanz, HE; Read, AF; Richard, TL; Shreve, MJ; Silverman, J; Veith, TL; Watson, JE | 1 |
1 review(s) available for naproxen and hydroxychloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for naproxen and hydroxychloroquine
| Article | Year |
|---|---|
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Double-Blind Method; Eye Diseases; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Male; Middle Aged; Naproxen; Severity of Illness Index; Time Factors; Treatment Outcome | 1999 |
8 other study(ies) available for naproxen and hydroxychloroquine
| Article | Year |
|---|---|
Drug-induced peripheral neuropathy in a patient with psoriatic arthritis.
Topics: Adult; Arthritis; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Naproxen; Neural Conduction; Peripheral Nervous System Diseases; Psoriasis | 1987 |
Cardiac tamponade in systemic lupus erythematosus.
Topics: Adult; Cardiac Tamponade; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Naproxen; Pericardial Effusion | 1988 |
Pharmacologic treatment of juvenile arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Juvenile; Aspirin; Child; Gold; Humans; Hydroxychloroquine; Naproxen; Penicillamine; Tolmetin | 1983 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Kikuchi-Fujimoto disease with cutaneous presentation in a patient with subacute cutaneous lupus erythematosus.
Topics: Anti-Inflammatory Agents; Biopsy; Drug Therapy, Combination; Female; Histiocytes; Histiocytic Necrotizing Lymphadenitis; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Lymphatic Diseases; Middle Aged; Naproxen; Prednisone; Treatment Outcome | 2012 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin | 2020 |
Comparison of individual and combination treatments with naproxen, prednisolone and hydroxychloroquine to treat Complete Freund's Adjuvant induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Experimental; Erythrocytes; Female; Freund's Adjuvant; Humans; Hydroxychloroquine; Inflammation; Male; Naproxen; Oxidative Stress; Prednisolone; Rats; Rats, Wistar | 2021 |
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.
Topics: Acetaminophen; Ampicillin; Animals; Anti-Bacterial Agents; COVID-19; Dexamethasone; Doxycycline; Environmental Monitoring; Humans; Hydroxychloroquine; Naproxen; Ofloxacin; Pandemics; Pennsylvania; Pharmaceutical Preparations; Soil; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |